Brevan Howard Capital Management LP Novavax Inc Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Novavax Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 12,413 shares of NVAX stock, worth $111,717. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,413
Previous 63,520
80.46%
Holding current value
$111,717
Previous $804,000
80.6%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding NVAX
# of Institutions
291Shares Held
93.4MCall Options Held
6.95MPut Options Held
9.4M-
Vanguard Group Inc Valley Forge, PA15.4MShares$139 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$107 Million0.0% of portfolio
-
Shah Capital Management9.82MShares$88.3 Million40.63% of portfolio
-
State Street Corp Boston, MA7.69MShares$69.2 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.94MShares$53.4 Million0.07% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $704M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...